Hepatitis B surface antigen (HBsAg) prevalence in Syria
Syria: Hepatitis B surface antigen (HBsAg) prevalence was 2.9% in 2024. ▬ Flat
Latest (2024)
2.9%
Change on year
down 9.4%
World rank
6th
of 194 countries
All-time high
4.0%
in 2019
All-time low
2.6%
in 2015
Years of data
10
2015–2024
Hepatitis B surface antigen (HBsAg) prevalence in Syria, 2015–2024
Source: World Health Organization, Global Health Observatory.
Analysis
Syria recorded 2.9% for hepatitis b surface antigen (hbsag) prevalence in 2024.
The figure is down 9.4% on the previous year and up 11.5% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Syria peaked at 4.0% in 2019 and was at its lowest, 2.6%, in 2015.
Syria ranks 6th of 194 countries on this measure, in the top 10%.
Hepatitis B surface antigen (HBsAg) prevalence in Syria, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 2.6% | — |
| 2016 | 3.4% | +30.8% |
| 2017 | 3.8% | +11.8% |
| 2018 | 3.6% | -5.3% |
| 2019 | 4.0% | +11.1% |
| 2020 | 3.8% | -5.0% |
| 2021 | 3.6% | -5.3% |
| 2022 | 3.4% | -5.6% |
| 2023 | 3.2% | -5.9% |
| 2024 | 2.9% | -9.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 3.5% | 2.6% | 4.0% | 5 |
| 2020s | 3.4% | 2.9% | 3.8% | 5 |
Countries ranked near Syria
More health data for Syria
- Un projection of annual infant deaths, annual growth rate -2.1 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8632 % change on previous year (2090)
- Un projection of annual infant deaths 1,491 (2100)
- Heat deaths vs projected death rates 1,122 (2090)
- Deaths in armed conflicts by country 73 (2026)
- Deaths in armed conflicts by region 73 (2026)
- Age population, age 20, female, interpolated 285,767 (2025)
- Age population, age 11, male, interpolated 247,361 (2025)
- Age population, age 12, female, interpolated 260,251 (2025)
- Age population, age 21, female, interpolated 289,630 (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Syria?
- Hepatitis b surface antigen (hbsag) prevalence in Syria was 2.9% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Syria?
- The highest recorded value was 4.0% in 2019.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Syria?
- The lowest recorded value was 2.6% in 2015.
- How does Syria rank for hepatitis b surface antigen (hbsag) prevalence?
- Syria ranks 6th out of 194 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Syria?
- Over the last ten years it is up 11.5%. The long-run trend across the full record is flat.
- Where does this Syria data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).